Clinigen Group plc Annual Report and Accounts and notice of AGM (2915O)
October 03 2019 - 1:00AM
UK Regulatory
TIDMCLIN
RNS Number : 2915O
Clinigen Group plc
03 October 2019
3 October 2019
Posting of Annual Report and Accounts and notice of AGM
Clinigen Group plc (AIM: CLIN, 'Clinigen' or 'the Group'), the
global pharmaceuticals and services group, announces that its
Annual Report and Accounts for the year ended 30 June 2019 is now
available on the Group's website at www.clinigengroup.com.
Copies of the Annual Report and Accounts will be also posted to
shareholders later today.
The Group will hold its Annual General Meeting ('AGM') on 26
November 2019 at 10.00am at Instinctif Partners' offices, 65
Gresham Street, London EC2V 7NQ. Shaun Chilton, Group Chief
Executive Officer, will give a presentation at the AGM. The slides
will be made available on the Group's website after the meeting. No
new material information will be provided.
- Ends -
Contact Details
Clinigen Group plc Tel: +44 (0) 1283 495
010
Peter Allen, Chairman
Matt Parrish, Head of Investor Relations
Numis Securities Limited - Nominated Adviser Tel: +44 (0) 20 7260 1000
& Joint Broker
James Black / Freddie Barnfield / Freddie
Naylor-Leyland
RBC Capital Markets - Joint Broker Tel: +44 (0) 20 7653 4000
Marcus Jackson / Elliot Thomas
Instinctif Partners Tel: +44 (0) 20 7457 2020
Adrian Duffield / Melanie Toyne-Sewell /
Rozi Morris Email: clinigen@instinctif.com
About Clinigen Group
Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and
services company with a unique combination of businesses focused on
providing ethical access to medicines. Its mission is to deliver
the right medicine to the right patient at the right time through
three areas of global medicine supply; clinical trial, unlicensed
and licensed medicines. The Group has sites in North America,
Europe, Africa and Asia Pacific.
Clinigen now has over 1,100 employees across five continents in
14 countries, with supply and distribution hubs and operational
centres of excellence in key long-term growth regions. The Group
works with 22 of the top 25 pharmaceutical companies; interacting
with over 15,000 registered users across over 100 countries,
shipping approximately 6.4 million units in the year.
For more information on Clinigen, please visit
www.clinigengroup.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ACSCKDDQABDKBKK
(END) Dow Jones Newswires
October 03, 2019 02:00 ET (06:00 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Apr 2024 to May 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From May 2023 to May 2024